What Is the GSEU ETF? A Complete Guide to Returns, Fees, Holdings, and Alternative ETFs
The Goldman Sachs ActiveBeta Europe ETF (GSEU) combines value, momentum, quality, and low volatility factors to diversify across developed European equities. When assessing its outlook, comparing its factor strategy with similar European and developed-market ETFs is the key selection criterion.
What Is the Goldman Sachs ActiveBeta Europe ETF?
This smart beta ETF tracks the Goldman Sachs ActiveBeta Europe equity index. It combines four factor scores (value, momentum, quality, and low volatility) to select and weight stocks in developed European markets.
It suits investors who want to diversify beyond the U.S. market into developed Europe while also pursuing the potential for factor-based excess returns.
The ETF is managed by Goldman Sachs using a passive (index-tracking) approach.
How Does the Goldman Sachs ActiveBeta Europe ETF Invest?
| Item | Details |
|---|---|
| Tracked index | Goldman Sachs ActiveBeta Europe equity index |
| Management style | Passive (factor-based smart beta) |
| Rebalancing frequency | Quarterly |
| Dividend frequency | Semiannual |
| Expense ratio | 0.25% |
The ETF tracks a rules-based index that combines four factor scores (value, momentum, quality, and low volatility) to select developed European stocks and adjust their weights. Unlike simple market-cap weighting, it spreads factor exposure in a balanced way, aiming for better risk-adjusted returns than the broader market.
- Smart beta design combining four factors (value, momentum, quality, and low volatility)
- Broad diversification across developed European markets
Goldman Sachs ActiveBeta Europe ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) are $169.5M, and the expense ratio is 0.25% per year.
Unlike the large international and developed-market ETFs shown in the table, it uses factor weighting, so its method of calculating stock weights differs from that of market-cap-weighted indexes.
Goldman Sachs ActiveBeta Europe ETF Performance and Trends
The ETF moves in line with developed European markets overall and with factor performance. Its results relative to the market index have tended to diverge depending on whether the value and momentum factors are showing relative strength.
Inflows tend to rise when demand for international diversification grows, such as when allocations to Europe expand or the dollar weakens, and the ETF is also affected by the broader fund-flow environment within the factor ETF category.
Goldman Sachs ActiveBeta Europe ETF Strengths and Weaknesses
Its strengths are factor-based diversification and exposure to developed European markets, while its weaknesses are lower recognition and liquidity than simple market-cap-weighted ETFs.
💪 Key Strengths
⚠️ Points to Watch
Goldman Sachs ActiveBeta Europe ETF Alternatives and Related Products
The three ETFs shown in the table, VEA, IEFA, and VXUS, are market-cap-weighted funds offering broad developed-market or international exposure. Unlike GSEU, they follow index weights as they are, without factor selection. There are also products such as VT, which widens exposure to global equities, and the long-established EFA ETF, which tracks the MSCI EAFE and differs in its fee structure. The GSLC ETF, a U.S. large-cap factor fund from the same Goldman Sachs ActiveBeta family, can also be an alternative for comparing U.S. factor exposure.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| Vanguard FTSE Developed Markets ETF | $70.12 | +0.5% | $228.5B | 0.03% | 2.43% | +15.5% | |
| iShares Core MSCI EAFE ETF | $97.02 | +0.3% | $190.0B | 0.07% | 3.39% | +10.0% | |
| Vanguard Total International Stock ETF | $84.00 | +0.3% | $161.8B | 0.05% | 2.36% | +13.2% | |
| Vanguard Total World Stock ETF | $158.59 | +0.5% | $82.4B | 0.06% | 1.52% | +14.0% | |
| iShares MSCI EAFE ETF | $104.06 | +0.4% | $76.9B | 0.32% | 3.23% | +10.0% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| ASML | ASML Holding NV | 0.07% | $1676.69 | +2.8% | $646.2B | 41.3 | 0.63% |
| Goldman Sachs Data Enhanced International Equity ETF | 0.03% | $41.49 | +0.4% | $0.0M | - | - | |
| NVS | Novartis AG ADR | 0.04% | $153.93 | +0.2% | $281.8B | 23.2 | 2.82% |
| Goldman Sachs Technology Opportunities ETF | 0.02% | $49.57 | +1.2% | $0.0M | - | - | |
| AZN | Astrazeneca plc | 0.04% | $168.45 | -0.2% | $261.2B | 25.2 | 1.98% |
| HSBC | HSBC Holdings plc ADR | 0.04% | $93.90 | +1.3% | $321.8B | 13.4 | 4.43% |
Goldman Sachs ActiveBeta Europe ETF Investor Checkpoints
These are the points to review before investing in GSEU. Because of its factor strategy and European regional exposure, it requires additional checks beyond those for a simple market-cap-weighted international ETF.
| Checkpoint | What to check | Current status |
|---|---|---|
| 💵 Expense ratio | Check the cumulative cost impact over a long holding period | Needs to be checked against the category average |
| 💧 Liquidity | Check daily trading value and bid-ask spread | Relatively low compared with large international ETFs |
| 📊 Factor exposure | Changes in the weights of value, momentum, quality, and low volatility | Maintained through quarterly rebalancing |
| 💱 Currency | Impact of currency swings such as the euro and the pound | No currency hedge applied |
Limited liquidity and periods of relative underperformance in the factor strategy are the main drivers of short-term volatility. During corrections in European markets, the ETF is exposed to declines much like market-cap-weighted ETFs.
It is a suitable choice for investors who want factor-based diversification across developed European markets. For simple market-cap weighting, VEA and IEFA can be alternatives, and for broad international diversification, VXUS and VT can serve that role.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of July 2, 2026.